Document ID: chunk:federal_register_of_legislation:F2018L01165:clause:1_1
Version: federal_register_of_legislation:F2018L01165
Segment Type: clause
Provision Reference: sch 1 cl 1
Character Range: 6592–8401

1               Definitions
In this instrument:
                               active mycobacterial disease means an illness in which tuberculosis bacteria or atypical mycobacteria are multiplying and inducing an inflammatory response.
                               BCG therapy means treatment with the Bacille Calmette-Guerin vaccine.
                                infection as specified means:
         (a)          clinical or laboratory evidence of a bowel infection; or
         (b)          clinical or laboratory evidence of a sexually acquired urogenital infection (including proctitis and excluding genital warts and herpes simplex); or
         (c)          clinical or laboratory evidence of an infection with Staphylococcus aureus, Chlamydia pneumoniae, Chlamydia psittaci or Chlamydia trachomatis.
                                  MRCA means the Military Rehabilitation and Compensation Act 2004.
                                  reactive arthritis—see subsection 7(2).
                                  relevant service means:
         (a)          eligible war service (other than operational service) under the VEA;
         (b)          defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
         (c)          peacetime service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
                                  terminal event means the proximate or ultimate cause of death and includes the following:
         (a)           pneumonia;
         (b)           respiratory failure;
         (c)           cardiac arrest;
         (d)           circulatory failure; or
         (e)           cessation of brain function.
                                  VEA means the Veterans' Entitlements Act 1986.